SCHEMBL57066

SCHEMBL57066

[CH2]CC(C)CC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10604544 0.94 TSHR (0.33)
SCHEMBL5985622 0.85
SCHEMBL9438344 0.84 TSHR (0.32)
SCHEMBL23581523 0.80 LMNA (0.43)
SCHEMBL599901 0.76 TSHR (0.47)
SCHEMBL38014 0.76
SCHEMBL585568 0.76
SCHEMBL55157 0.76 ALDH1A1 (0.30)
SCHEMBL8813708 0.73
SCHEMBL231488 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110494143-B Phospholipid derivatives and their use as pharmaceuticals 捷克共和国科学院分子遗传学研究所 2022-12-20 CN claimed
CN-115135323-A Pharmaceutical composition 深圳市药欣生物科技有限公司 2022-09-30 CN claimed
EP-3606534-B1 PHOSPHOLIPID DERIVATIVES AND THEIR USE AS MEDICAMENTS USTAV MOLEKULARNI GENETIKY AV CR V V I (CZ) 2021-05-12 EP claimed
US-20200102333-A1 PHOSPHOLIPID DERIVATIVES AND THEIR USE AS MEDICAMENTS Smart Brain s.r.o. (CZ) 2020-04-02 US claimed
EP-3606534-A1 PHOSPHOLIPID DERIVATIVES AND THEIR USE AS MEDICAMENTS Ustav Molekularni Genetiky Akademie Ved CR, V.V.I. (CZ) 2020-02-12 EP claimed
WO-2018184604-A1 PHOSPHOLIPID DERIVATIVES AND THEIR USE AS MEDICAMENTS USTAV MOLEKULARNI GENETIKY AV CR, V.V.I. (CZ) 2018-10-11 WO claimed
US-20130087745-A1 SOLUBLE PRECURSORS AND SOLUTION-BASED PROCESSES FOR PHOTOVOLTAICS PRECURSOR ENERGETICS, INC. (US) 2013-04-11 US claimed
US-8258325-B2 For example diisononyl isosorbide; renewable plasticizers; replace phthalates which have health concerns EVONIK OXENO GMBH (DE) 2012-09-04 US claimed
EP-2064211-A1 IMIDAZO[1,2-a]PYRIDINE HYDROXYMATE COMPOUNDS THAT ARE INHIBITORS OF HISTONE DEACETYLASE S*Bio Pte Ltd (SG) 2009-06-03 EP claimed
WO-2008036046-A1 IMIDAZO[l,2-a]PYRIDINE HYDROXYMATE COMPOUNDS THAT ARE INHIBITORS OF HISTONE DEACETYLASE S*BIO PTE LTD (SG) 2008-03-27 WO claimed
US-6452009-B1 A LARGE NUMBER OF RELATED ANALOGS ARE THEN SYNTHESIZED IN ORDER TO DEVELOP A STRUCTURE-ACTIVITY RELATIONSHIP LION BIOSCIENCE AG (DE) 2002-09-17 US claimed
US-12043762-B2 Compositions and methods thereof THE BOEING COMPANY (US) 2024-07-23 US disclosed
US-12037329-B2 SphK inhibitors and methods of making and using same WASHINGTON UNIVERSITY (US) 2024-07-16 US disclosed
CN-112689634-B SMAD3 inhibitors 莫扎制药有限公司 2024-07-16 CN disclosed
US-20240226342-A1 REACTIVE OXYGEN SPECIES IMAGING AGENTS WASHINGTON UNIVERSITY (US) 2024-07-11 US disclosed
US-4206231-A Hypoglycaemically active 2-alkyl- or -alkenyl-hydrazono propionic acid derivatives BOEHRINGER MANNHEIM GMBH (DE) 1980-06-03 US disclosed
EP-0004577-A2 Process for preparing 2,2-dimethylol alkanals BAYER AG (DE) 1979-10-17 EP disclosed
EP-0001144-A1 N-substituted 2-hydrazono-propionic acid derivatives, process for their preparation and pharmaceutical compositions containing them Roche Diagnostics GmbH (DE) 1979-03-21 EP disclosed
US-4122290-A FORMALDEHYDE REACTED WITH AN ALDEHYDE, 2,2-DIMETHYLOLALKANE HYDROGENATED BAYER AKTIENGESELLSCHAFT (DE) 1978-10-24 US disclosed
US-4107136-A Synthetic resin stabilizer comprising an organic phosphite and a carbonate ARGUS CHEMICAL CORPORATION (US) 1978-08-15 US disclosed